Targeted Radiotherapy for Neuroblastoma: Size Matters
Author Information
Author(s): M.N. Gaze, R.J. Mairs, S.M. Boyack, T.E. Wheldon, A. Barrett
Primary Institution: University of Glasgow
Hypothesis
Smaller tumours of sub-millimetre dimensions are relatively resistant to '131I-mIBG therapy.
Conclusion
The study concludes that smaller micrometastases may be spared by '131I-mIBG therapy, indicating a need for alternative treatment strategies.
Supporting Evidence
- Smaller tumours are more difficult to cure with '131I-mIBG therapy.
- Larger spheroids showed greater vulnerability to '131I-mIBG treatment.
- The study suggests combining '131I-mIBG with other treatments for better outcomes.
Takeaway
This study found that smaller cancer lumps are harder to treat with a specific type of radiation therapy, so doctors might need to use other treatments alongside it.
Methodology
The study used multicellular tumour spheroids of human neuroblastoma cells to test the effects of different concentrations of '131I-mIBG.
Limitations
The study was conducted in vitro, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website